Journal
MATERIALS
Volume 10, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/ma10020170
Keywords
phenylboronic acid; glucose-sensitivity; drug delivery; diabetes therapy
Categories
Funding
- National Natural Science Foundation of China [51403075, 51673190, 51303174, 51390484]
- Department of Housing and Urban-Rural Development of Jilin Province [2014-K1-020]
Ask authors/readers for more resources
In recent years, glucose-sensitive drug delivery systems have attracted considerable attention in the treatment of diabetes. These systems can regulate payload release by the changes of blood glucose levels continuously and automatically with potential application in self-regulated drug delivery. Boronic acid (BA), especially phenylboronic acid (PBA), as glucose-sensitive agent has been the focus of research in the design of glucose-sensitive platforms. This article reviews the previous attempts at the developments of PBA-based glucose-sensitive drug delivery systems regarding the PBA-functionalized materials and glucose-triggered drug delivery. The obstacles and potential developments of glucose-sensitive drug delivery systems based on PBA for diabetes treatment in the future are also described. The PBA-functionalized platforms that regulate drug delivery induced by glucose are expected to contribute significantly to the design and development of advanced intelligent self-regulated drug delivery systems for treatment of diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available